Notification regarding unquoted securities – CUV 2021 Announcements . Financial . Regulatory 16.09.2021
CLINUVEL Investor Webinar Financial Results Year Ended 30 June 2021 2021 Announcements . Corporate . Financial . Regulatory 27.08.2021
Corporate Presentation – FY2021 Results 2021 Announcements . Corporate . Financial . Presentation . Regulatory 26.08.2021
Appendix 4E and Preliminary Financial Report 2021 Announcements . Corporate . Financial . Regulatory 26.08.2021
CLINUVEL Delivers Record Revenues and Profit 2021 Announcements . Corporate . Financial . Regulatory 26.08.2021
SCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV) 2021 Announcements . Clinical . Corporate . Regulatory 24.03.2021
SCENESSE® Granted Market Access In Israel 2021 Announcements . Clinical . Corporate . Regulatory 11.02.2021
Media Release – TGA approves Australian drug to protect patients from light and sun Clinical . News . Regulatory 27.10.2020
Media Release – First patient dosed in SCENESSE® DNA Repair Program Clinical . News . Regulatory 14.09.2020
Media Release (ASX) – CLINUVEL progresses innovative DNA Repair Program Clinical . News . Regulatory 10.09.2020